论文部分内容阅读
目的:观察莫沙比利与黛立新和复方阿嗪米特联用治疗功能性消化不良的临床疗效。方法:90例功能性消化不良患者随机分为两组。莫沙比利联用黛立新和复方阿嗪米特组(治疗组)46例;单用莫沙比利组(对照组)44例。两组疗程为4周,观察其临床症状变化和不良反应。结果:治疗组总有效率明显高于对照组(P<0.05)。结论:莫沙比利与黛立新和复方阿嗪米特联用治疗功能性消化不良症状疗效满意,具有较好的安全性。
Objective: To observe the clinical efficacy of mosapride in combination with Dai Lixin and compound azintom in the treatment of functional dyspepsia. Methods: Ninety patients with functional dyspepsia were randomly divided into two groups. Forty-six cases were treated with mosapride and dexrazoxane (treatment group), and 44 cases were treated with mosapride alone (control group). The two groups of treatment for 4 weeks to observe the changes in clinical symptoms and adverse reactions. Results: The total effective rate in the treatment group was significantly higher than that in the control group (P <0.05). Conclusion: Mosapride combined with Dai Lixin and compound alizamine in treating functional dyspepsia has satisfactory curative effect and good safety.